The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials

@article{Su2019TheEA,
  title={The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials},
  author={S. Su and N. He and P. Men and C. Song and S. Zhai},
  journal={Osteoporosis International},
  year={2019},
  volume={30},
  pages={1175-1186}
}
SummaryIn our systematic review and meta-analysis, we comprehensively evaluated menatetrenone in the management of osteoporosis. We found that menatetrenone decreased the ratio of undercarboxylated osteocalcin to osteocalcin (ucOC/OC) and improved lumbar BMD compared with placebo based on the 18 studies assessed. However, its benefit in fracture risk control was uncertain.IntroductionWe performed a systematic review and meta-analysis of the efficacy and safety of menatetrenone in managing… Expand
Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials
TLDR
For post-menopausal or osteoporotic patients, there is no evidence that vitamin K affects bone mineral density or vertebral fractures; it may reduce clinical fractures; however, the evidence is insufficient to confirm this. Expand
The secular trends in the use of medications for osteoporosis in South Korea using Intercontinental Medical Statistics Health Sales Audit 2006–2018
TLDR
Prescription patterns using DOT are changing probably due to the increase in older adult patients and severely osteoporotic patients, and there are other issues including safety and the launching of new drugs. Expand
Issues related to the research on vitamin K supplementation and bone mineral density
TLDR
Vitamin K1, MK-4, and menaquinone-7 (MK-7) have been the most studied in relation to osteoporosis and bone loss and may function as a transcription regulating factor for the genes that participate in the formation of collagen matrix and bone homeostasis. Expand
Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health.
TLDR
Data suggest that VitK2 supplementation might improve bone quality and reduce fracture risk in osteoporotic patients, potentially enhancing the efficacy of Ca ± vitD and Mg supplementation, but data regarding the effectiveness of vitK2 and MG supplementation on bone are inconclusive. Expand
Nutritional Supplements and Skeletal Health
TLDR
The effect size of nutrient interventions are relatively small, requiring large sample sizes for trials with bone outcomes, may be difficult to blind, and the impact of supplementation may depend on baseline intake, however, nutrition is the only intervention that can be implemented life long and on a population wide basis. Expand
Menatetrenone facilitates hematopoietic cell generation in a manner that is dependent on human bone marrow mesenchymal stromal/stem cells
TLDR
The findings indicate that pharmacological treatment with menatetrenone bestows a unique hematopoiesis-supportive capability on BM-MSCs, which may contribute to the clinical improvement of cytopenia. Expand
Aqueous Extract of Salvia miltiorrhiza Bunge-Radix Puerariae Herb Pair Attenuates Osteoporosis in Ovariectomized Rats Through Suppressing Osteoclast Differentiation
TLDR
DG significantly restored bone loss and deficiency of type II collagen, decreased TRAP and Cathepsin K positive areas in femur, and decreased the serum osteoclast-specific cytokine RANKL and OPG release in OVX rats exhibiting its protective effect against osteoporosis. Expand

References

SHOWING 1-10 OF 66 REFERENCES
Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial
TLDR
Menatetrenone is an effective and safe choice in the treatment of postmenopausal osteoporosis in Chinese women and the safety profile of menateterenone was similar to alfacalcidol. Expand
Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials
TLDR
For post-menopausal or osteoporotic patients, there is no evidence that vitamin K affects bone mineral density or vertebral fractures; it may reduce clinical fractures; however, the evidence is insufficient to confirm this. Expand
Vitamin K to prevent fractures in older women: systematic review and economic evaluation.
TLDR
The base-case results favoured vitamin K1, but this relied on many assumptions, particularly on the efficacy of preventing hip and vertebral fractures, which is unlikely that the present prescribing policy would be altered. Expand
Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
TLDR
This systematic review suggests that supplementation with phytonadione and menaquinone-4 reduces bone loss and in the case of the latter, there is a strong effect on incident fractures among Japanese patients. Expand
Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials
TLDR
The hypothesis that vitamin K2 plays kind of a role in the maintenance and improvement of vertebral BMD and the prevention of fractures in postmenopausal women with osteoporosis seemed to support. Expand
Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials
TLDR
Subgroup analysis revealed that ethnic difference, gender, and vitamin K type were associated with variable effects on BMD at the lumbar spine and the modest overall treatment effects for vitamin K on B MD observed in this review may be biased and should be interpreted with caution. Expand
Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules
TLDR
In conclusion, menatetrenone therapy was not effective for preventing vertebral fractures in the full analysis set of this study, but the results suggested that it may prevent vertebra fractures in patients with more advanced osteoporosis. Expand
Vitamin K2 Therapy for Postmenopausal Osteoporosis
TLDR
Positive evidence for the effects of menatetrenone monotherapy on fracture incidence in postmenopausal women with osteoporosis is revealed. Expand
Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
TLDR
It is suggested that vitamin K2 at a dosage of 90 mg/day is effective in maintaining peripheral cortical bone density and is safe in treatment for osteoporosis. Expand
Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study.
TLDR
It is observed that there are significant reductions in the incidence of vertebral fractures with hormone replacement therapy, etidronate, and calcitonin, and significant improvements in bone mineral density with hormone Replacement therapy and calcitusin. Expand
...
1
2
3
4
5
...